Phase 1 Clinical Trial of PNEUMOSTEM® Treatment in Premature Infants With

Updated 05/17/2024

Status Completed

Clinical Trial Summary

Phase 1 clinical trial for the safety and dose determination of Pneumostem (human umbilical cord blood derived mesenchymal stem cells) in the premature infants with intraventricular hemorrhage (IVH, grade 3-4)

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT02274428
Study type	Interventional
Source	Samsung Medical Center
Contact
Status	Completed
Phase	Phase 1
Start date	October 2014
Completion date	December 2016

See also
	Status	Clinical Trial	Phase
	Completed	`NCT03265613` - Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis	Phase 1/Phase 2
	Not yet recruiting	`NCT04711200` - LYell SYndrome MEsenchymal Stromal Cells Treatment	Phase 1/Phase 2
	Recruiting	`NCT04626583` - Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells	Phase 1
	Active, not recruiting	`NCT03874572` - Allogeneic Mesenchymal Stem Cells for Radiation-induced Hyposalivation and Xerostomia/Dry Mouth	Phase 1
	Recruiting	`NCT04785027` - Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis	Phase 1/Phase 2
	Recruiting	`NCT05602116` - ASC - Autism Study	Phase 1
	Recruiting	`NCT04918706` - Allogeneic MSC Treatment for Pulmonary Emphysema	Phase 2
	Completed	`NCT03392311` - Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment in Patients With Moderate to Severe Psoriasis	Phase 1/Phase 2
	Recruiting	`NCT05204329` - Safety of Topical Mesenchymal Stromal Cell Secretome for Ocular Surface Disease	Early Phase 1
	Recruiting	`NCT05595681` - Effect of Mesenchymal Stem Cells on Healing of Foot Ulcers in Diabetes Patients.	Phase 1
	Not yet recruiting	`NCT03745417` - Efficacy and Safety of Expanded UCMSCs On Patients With Moderate to Severe Psoriasis	Phase 1/Phase 2
	Enrolling by invitation	`NCT03876197` - Mesenchymal Stem Cells for Radiation-induced Xerostomia	Phase 1/Phase 2
	Terminated	`NCT04371393` - MSCs in COVID-19 ARDS	Phase 3
	Completed	`NCT04275024` - Efficacy and Safety of AD-MSCs Plus Calpocitriol Ointment and PSORI-CM01 Granule in Psoriasis Patients	N/A